Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead

The company's latest launch in this field, Alyftrek, can be taken once daily -- versus twice a day for the one before that.

Vertex Pharmaceuticals: I Was Wrong About Its Near-Term Prospects (Rating Upgrade)

Vertex Pharmaceuticals' revenue from its cystic fibrosis franchise grew 10% quarter-on-quarter. Click here to see why VRTX ...
STAT

Advocacy groups form a buyer’s club to obtain generic versions of pricey Vertex cystic fibrosis drug

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...
Pharmabiz

Zealand Pharma signs US$ 100 million value royalty purchase & sale agreement with Royalty Pharma related to rusfertide

Zealand Pharma signs US$ 100 million value royalty purchase & sale agreement with Royalty Pharma related to rusfertide: Copenhagen, Denmark Friday, August 14, 2026, 11:00 Hrs [IST ...

Vertex Pharmaceuticals Incorpor (VRTX) Stock Forecasts

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
WhoWhatWhy on MSNOpinion

Slipping through the cracks: How medicine has gotten better and worse

There may be no worse place to be than in a body that’s failing when the doctors can’t tell you what’s wrong. Slipping ...